Migraine Briefs

Brainstem Raphe and Depression in Patients With Migraine


 

Transcranial sonography (TCS) signal alteration of brainstem raphe (BR) can be a biomarker for depression in migraine but is not associated with migraine headache itself, a new study found. Forty-two patients who had migraine without aura and 40 healthy controls were recruited for the study. Echogenicity of lentiform nuclei (LN), caudate nuclei (CN), substantia nigra (SN) and BR, width of the frontal horns of the lateral ventricles, and the third ventricle were assessed with TCS. Researchers found:

  • There were no significant differences between migraineurs and controls in the width of front horn of the lateral ventricle, width of third ventricle, as well as in the echogenicity of SN, CN, LN and BR.
  • More patients with migraine were detected with increased echogenicity of CN and LN compared with controls.
  • Patients with hypoechogenic BR had significantly higher Hamilton Rating Scale for Depression (HAM-D) and Hospital Anxiety and Depression Scale depression subscale (HADS-D) scores than those with normal BR signal.

Tao WW, et al. Hypoechogenicity of brainstem raphe correlates with depression in migraine patients. [Published online ahead of print May 15, 2019]. J Headache Pain . doi: 10.1186/s10194-019-1011-2.

Recommended Reading

Which migraineurs seek care from a neurologist?
Migraine ICYMI
White light exposure is associated with acute risk of headache in migraine
Migraine ICYMI
Atypical Interactions of Cortical Networks in Chronic Migraine
Migraine ICYMI
Dry Eye Symptoms in Individuals with Migraine
Migraine ICYMI
Periodontal Inflammation in Patients with Migraine
Migraine ICYMI
A plurality of migraineurs seeks care from primary care physicians
Migraine ICYMI
Nearly 20% of migraineurs use opioids for migraine
Migraine ICYMI
Atogepant shows safety, efficacy for migraine prevention
Migraine ICYMI
Exposure to patients with migraine increases likelihood of stigmatizing attitudes
Migraine ICYMI
Efficacy of erenumab is sustained over more than 4 years of treatment
Migraine ICYMI